Dana Farber - Defy Cancer
Dana Farber Cancer Institute
The Jimmy Fund
What Happens Here Matters Everywhere

What Happens Here Matters Everywhere

Dana-Farber Cancer Institute is leading the way in cancer research, patient care, and innovation to reduce the burden for those with cancer in New England and around the world.  

Dana-Farber by the Numbers

See how Dana-Farber Cancer Institute supports life-changing cancer care and treatment.

50%+

Cancer drugs approved
by the FDA received substantive contribution from Dana-Farber

1,100+

Clinical trials offered
further advancing patient care and treatment

96,288

Patients treated in 2024
who received care tailored to their specific needs

8

Campuses across New England
creating more access to high-quality care

Dr. Ben Ebert

A Message from our President and CEO

As we embark on a bold new chapter in the future of cancer care and research, we are propelled by what you have made possible for our patients and families. Dana-Farber Cancer Institute is at an inflection point: building the first adult inpatient cancer hospital in New England—devoted entirely to cancer—developing our clinical partnership with Beth Israel Deaconess Medical Center, and deepening our commitment to cutting-edge research and excellence in patient care.

Your partnership with Dana-Farber drives this progress and I look forward to all we will accomplish. Together, we are redefining what is possible in cancer medicine.

Benjamin L. Ebert, MD, PhD
President and CEO, Dana-Farber Cancer Institute
Richard and Susan Smith Professor of Medicine, Harvard Medical School
Director, Dana-Farber/Harvard Cancer Center

What We Do Here Changes Lives

Loading...
Building the Future

Building the Future

The building of the new, state-of-the-art inpatient cancer hospital, a clinical collaboration with Beth Israel Deaconess Medical Center, has been approved by the Boston Planning and Development Agency Board. This transformative project will further our dedication to bringing research to life with our bench-to-bedside approach, and our commitment to a patient-first care model.

Breaking Barriers

Breaking Barriers

Like most scientists, William G. Kaelin, Jr., MD, likes solving puzzles—especially when they can help patients. As a leader at Dana-Farber Cancer Institute, his work has been credited with life-altering breakthroughs, including receiving the Nobel Prize in 2019 for discoveries of how cells sense and adapt to oxygen availability. His personal experiences, as well as his dedication to patients, help fuel his work every day.

Like most scientists, William G. Kaelin, Jr., MD, likes solving puzzles—especially when they can help patients. As a leader at Dana-Farber Cancer Institute, his work has been credited with life-altering breakthroughs, including receiving the Nobel Prize in 2019 for discoveries of how cells sense and adapt to oxygen availability. His personal experiences, as well as his dedication to patients, help fuel his work every day.

Loading...

Awards and Recognition

U.S. News and World Report Best Cancer Hospital badge

2025-2026 Best Hospital

Ranked as the #1 hospital for cancer care in New England and #3 in the nation.

U.S. News and World Report Best Children’s Hospital badge

Top Children’s Hospital

Recognized as the nation’s #3 pediatric cancer center and the only cancer hospital ranked in the top 3 for adult and pediatric programs.

Four-Star Charity Navigator badge

Fiscal Responsibility

Dana-Farber has consistently received the highest, four-star rating, recognizing fiscally responsible operations.

Thank you for your interest in learning more about The Dana-Farber Campaign. You have been added to our email list and will receive updates on ways to join us in defying cancer. You can unsubscribe at any time.
There has been an issue submitting your request. Please try again.

Sign up to receive emails from Dana-Farber and the Jimmy Fund.

   Please leave this field empty
© Copyright 2025 Dana-Farber Cancer Institute, Inc. | Privacy Policy | Terms of Use | Accessibility | 10 Brookline Place West, 5th Floor, Brookline, Massachusetts 02445-7226 | 617-632-3019
Founded in Boston in 1947, Dana-Farber is a principal teaching affiliate of Harvard Medical School and a federally designated Comprehensive Cancer Center that develops and disseminates innovative patient therapies and scientific discoveries throughout the world. About Our Patient Stories: Dana-Farber shares patient stories which may include descriptions of actual medical results. Dana-Farber provides personalized care for each patient based on their unique needs; their experiences and results will vary.

At Dana-Farber we are committed to an inclusive community where human differences are valued and celebrated, and where all are welcome. We work every day to create an innovative, caring, and inclusive environment where each patient, family, and staff member feels valued and respected.